Summer 2025 - Vaccines

University of Toledo Awarded Funds to Explore Immune Response to Oral Thrush

The University of Toledo will receive $473,632 from the National Institute of Dental and Craniofacial Research to explore how the body’s immune system responds to the condition known as oral thrush. The three-year study, which will be led by Heather Conti, an associate professor of biological sciences, will examine how specialized immune responses in the mouth protect against fungal infections, particularly in vulnerable populations such as infants and immunocompromised individuals. The work has the potential to improve prevention and treatment strategies for a condition that disproportionately affects infants and can contribute to broader issues related to infant mortality and early childhood health. 

“As we work to address infant and oral health disparities across northwest Ohio throughout our nation, this award represents a meaningful step forward in both research and public health,” said Rep. Marcy Kaptur (D, Toledo). “The University of Toledo continues to lead in cutting-edge biomedical science, and I’m proud to see federal research dollars supporting work that could have a profound impact on our most vulnerable — our babies, children and families.” 

According to Kaptur’s office, the award is expected to support critical research and enhance local scientific capabilities, provide new training opportunities for students and early-career scientists in the region, and bolster northwest Ohio’s leadership in public health innovation.

References

 UT Receives Federal Funds to Study Oral Health, Infant Immune Response. University of Toledo The Blade, April 24, 2025. Accessed at www.toledoblade.com/local/education/2025/04/24/ut-receives-federal-funds-to-study-oral-health-infant-immune-response-treatment/stories/ 20250424111. 

BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.